• Users Online: 876
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2015  |  Volume : 31  |  Issue : 3  |  Page : 162-169

Auditory dysfunction in patients with type 2 diabetes mellitus with poor versus good glycemic control


1 Department of Neurology and Psychiatry, Assiut University, Assiut, Egypt
2 Audiology Unit, Department of ENT, Assiut University, Assiut, Egypt
3 Department of Clinical Pathology, Assiut University, Assiut, Egypt
4 Department of Medical Biochemistry, Assiut University, Assiut, Egypt
5 Department of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt

Correspondence Address:
Enass Sayed Mohamed
Audiology Unit, ENT Department, Faculty of Medicine, Assiut University, 40 Mohamed N. Serry Street, El-Gmhorea Avenue, Assiut
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1012-5574.161603

Rights and Permissions

Background Auditory functions among patients with type 2 diabetes mellitus (DM) are controversial regarding cochlear or neural changes and the relationship between these changes and serum level of glycosylated hemoglobin (HbA 1c %). Aim of the study The aim of the study was to investigate auditory dysfunctions in type 2 DM patients with poor versus good glycemic control. Materials and methods The present study was conducted on three groups: two diabetic groups with poor and good glycemic control (n = 18 and 14, respectively) based on serum HbA 1c % and one healthy control group (n = 30) matched with age, sex, and BMI. All participants were subjected to clinical assessment, audiometry, brainstem auditory evoked potential (BAEP), and evoked acoustic emissions transient evoked otoacoustic emissions and distortion product otoacoustic emissions (TEOAEs and DPOAEs). Results Diabetic patients with poor glycemic control had significantly elevated hearing thresholds compared with other groups at low and high frequencies in audiometry (P < 0.01 and P < 0.001). They showed significantly prolonged absolute latency in wave I and interpeak latency (III-V) in the BAEP test compared with other groups (P < 0.001). DM patients with poor glycemic control had significantly low amplitudes at all frequencies in the TEOAE test, as well as at high frequencies (4 and 6 kHz) on the DPOAE test, compared with other groups (P < 0.001 and P < 0.05, respectively). There were significant correlations between HbA 1c % and interpeak latency III-V (r = 0.340, P = 0.004) on the one hand and overall response of TEOAE amplitude (r = −0.471; P = 0.000) on the other. Conclusion Diabetic patients with poor glycemic control had worse auditory dysfunctions on both cochlear and neural findings.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3043    
    Printed93    
    Emailed0    
    PDF Downloaded339    
    Comments [Add]    
    Cited by others 1    

Recommend this journal